TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 24 filers reported holding TRILLIUM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $62,000 | -36.7% | 93,589 | +64.0% | 0.00% | -66.7% |
| Q4 2018 | $98,000 | -40.6% | 57,055 | +158.2% | 0.00% | -25.0% |
| Q4 2017 | $165,000 | +18.7% | 22,097 | -10.4% | 0.00% | -20.0% |
| Q4 2016 | $139,000 | -43.7% | 24,660 | +47.7% | 0.01% | -37.5% |
| Q3 2016 | $247,000 | -71.1% | 16,693 | -82.5% | 0.01% | -71.4% |
| Q2 2016 | $855,000 | -37.5% | 95,267 | -35.6% | 0.03% | -28.2% |
| Q1 2016 | $1,367,000 | – | 147,819 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 701,138 | $4,067,000 | 0.67% |
| Matrix Capital Management Company, LP | 2,288,560 | $13,274,000 | 0.33% |
| NEA Management Company, LLC | 1,250,000 | $7,250,000 | 0.31% |
| Stanley-Laman Group, Ltd. | 139,403 | $809,000 | 0.20% |
| Cormorant Asset Management, LP | 500,000 | $2,900,000 | 0.19% |
| Tekla Capital Management LLC | 468,399 | $2,717,000 | 0.10% |
| Wealth Alliance Advisory Group, LLC | 21,800 | $126,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $1,007,000 | 0.03% |
| Artal Group S.A. | 150,000 | $870,000 | 0.02% |
| Baker Brothers Advisors | 505,262 | $2,931,000 | 0.02% |